838 related articles for article (PubMed ID: 22845746)
1. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
2. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
Cheng CK; Lee CK; Lin CK
Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
[TBL] [Abstract][Full Text] [Related]
4. Intensive red blood cell transfusions and risk of alloimmunization.
Zalpuri S; Middelburg RA; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG; Zwaginga JJ
Transfusion; 2014 Feb; 54(2):278-84. PubMed ID: 23782244
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
6. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressants and alloimmunization against red blood cell transfusions.
Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
[TBL] [Abstract][Full Text] [Related]
8. Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.
Pereira A; Nomdedeu M; Aguilar JL; Belkaid M; Carrió A; Cobo F; Costa D; Rozman M; Sanz C; Nomdedeu B
Am J Hematol; 2011 Mar; 86(3):245-50. PubMed ID: 21328437
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch M; Weiss L; Lindlbauer N; Jungbauer C; Egle A; Rohde E; Greil R; Grabmer C; Pleyer L
Leuk Res; 2017 Aug; 59():12-19. PubMed ID: 28535394
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
Natukunda B; Schonewille H; van de Watering L; Brand A
Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes.
Cohen D; Hartung H; Evans P; Friedman DF; Chou ST
Transfusion; 2016 Jun; 56(6):1314-9. PubMed ID: 27080340
[TBL] [Abstract][Full Text] [Related]
13. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
14. Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis.
Kim HY; Cho EJ; Chun S; Kim KH; Cho D
Ann Lab Med; 2019 Mar; 39(2):218-222. PubMed ID: 30430787
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
16. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Singhal D; Kutyna MM; Chhetri R; Wee LYA; Hague S; Nath L; Nath SV; Sinha R; Wickham N; Lewis ID; Ross DM; Bardy PG; To LB; Reynolds J; Wood EM; Roxby DJ; Hiwase DK
Haematologica; 2017 Dec; 102(12):2021-2029. PubMed ID: 28983058
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
[TBL] [Abstract][Full Text] [Related]
18. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
20. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis.
Shukla JS; Chaudhary RK
Indian J Pathol Microbiol; 1999 Jul; 42(3):299-302. PubMed ID: 10862287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
